Crouzon syndrome, with an estimated birth prevalence of 16.5/1,000,000 (Cohen and Kreiborg, 1992) is possibly the mildest of FGFR2 craniosynostosis syndromes (Azoury et al., 2017). This evidence concerns the gene FGFR2 and Crouzon disease.